Home Pepper Bio

Pepper Bio

In operation
Seed Round Financing
Drug Developer

Basic Information

Pepper Bio is the world's first cross-omics drug discovery company, leveraging its proprietary cross-omics database and analytics to identify promising first-in-class therapies, rediscover new uses for existing therapies, and rescue drugs in development from failure. Founded in 2020, Pepper Bio is headquartered in Boston, Massachusetts.
Pepper Bio, Inc.
Boston,Massachusetts,United States of America
less than 15 people
January 01, 2020
contact@pepper.bio